Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 18, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Emily R Siegel1, James W Salazar2, Zian H Tseng3
1School of Medicine, University of California, San Francisco.
No abstract available in PubMed .